Picture

GH Research @ghresearch_plc

GH Research is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Joined September 2020
  • Tweets
    7
  • Followers
    185
  • Following
    0
  • Likes
    0
ghresearch_plc Profile Picture

GH Research @ghresearch_plc

3 months ago

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule investor.ghres.com/news-releases/…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

4 months ago

GH Research presented further results from a double-blind, placebo-controlled Phase 2b trial in TRD and a POC trial in PPD this week at the American Society of Clinical Psychopharmacology 2025 Annual Meeting – see our scientific publications here: ghres.com/scientific-pub…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

4 years ago

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates globenewswire.com/news-release/2…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

4 years ago

GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression globenewswire.com/news-release/2…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

5 years ago

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing #5meodmt #mentalhealth prnewswire.com/news-releases/…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

5 years ago

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress ghres.com/investors prnewswire.co.uk/news-releases/…

ghresearch_plc Profile Picture

GH Research @ghresearch_plc

5 years ago

GH001 is our innovative drug product for 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) administration via a proprietary inhalation approach. A Phase 1b study with GH001 in patients with Treatment-Resistant Depression is ongoing. See ghres.com to learn more.

Trends for United States

Perez
45 B posts
Dingler
2.007 posts
Project 2025
109 B posts
#BrysonTiller
Jihad
46,8 B posts
#RepDetroit
1.457 posts
Gaddis
Harmeet
1.355 posts
Flaherty
2.387 posts
Tork
charli
30 B posts
SBMM
2.543 posts
#BO7Beta
2.406 posts
Robert Morris
1.232 posts
Kwan
10,4 B posts
#BuiltForOctober
1.005 posts
#TSTheLifeofaShowgirl
44,6 B posts
Manchester
361 B posts
Baez
3.432 posts
Roma
99,2 B posts

You might like

Private, independent biopharmaceutical company pioneering the next generation of mental health treatments
Beckley Psytech
@BeckleyPsytech
2K Followers
A radically different approach to mental health treatment, through short-duration psychedelics with therapy | TSXV:DMT | OTCQB:DMTTF
Small Pharma
@SmallPharma
2K Followers
A Canadian Biotechnology company dedicated to the manufacture and sales of MDMA in service to the clinical research community. (MDMA.CSE) $MDMA
PharmAla Biotech
@PharmAlaBiotech
940 Followers
Welcome to a new era of psychedelics.
Psilera
@psilera
604 Followers
We are the Centre for Psychedelic Research at Imperial College London. We study psychedelics, how they work in the brain and their therapeutic potential 🙂
Centre for Psychedeli...
@Imperial_PRG
19K Followers
Co-Founder and ex-CEO of @ATAI_life - NASDAQ : $ATAI. Passionate about building companies, mental health and biotech. Views are my own. No investment advice.
Florian Brand
@flobrand
3K Followers
lawyer-turned-entrepreneur focussed on living a good, long life. https://t.co/qA77olMxey
Ronan Levy
@RonanDLevy
4K Followers
Creating new possibilities for everyone, everywhere living with a #mentalhealth disorder. Interested in #psychedelics & #drugdevelopment. $ATAI CEO @SriniGRao
atai Life Sciences
@atai_life
13K Followers
The Conscious Fund invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain.
The Conscious Fund
@ConsciousFundHQ
3K Followers
MindMed is a clinical stage biopharma company developing psychedelics and other novel treatments for brain health disorders. $MNMD $MMED
MindMed
@mindmedco
24K Followers
Changing Minds to Revolutionize Mental Healthcare $CYBN
CybinInc
@CybinInc
9K Followers
Training facilitators in psilocybin, ketamine & psychedelic therapy. Research, integration & harm reduction for a healthier future. #Psychedelics
Numinus
@NuminusTraining
8K Followers
Developing best in class medicines with clinically proven target to rapidly and durably treat depression and other underserved mental health disorders
Gilgamesh Pharma
@GilgameshRX
527 Followers